首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 製藥 > 製藥企業 > 全球主要生物藥品企業介紹
產業/市場分類
製藥 (4495)
肥胖症治療 (48)
非專利藥 (117)
疫苗 (168)
神經疾病 (175)
骨頭疾病治療 (41)
動物用醫藥 (18)
處方藥 (89)
規章 (107)
感染疾病 (318)
精神病 (80)
製藥企業 (506)
糖尿病 (157)
癌症 (838)
藥物開發 (1275)
DDS (173)
OTC 非處方藥 (147)
市場調查報告書

全球主要生物藥品企業介紹

Who's Developing What in Global Biopharmaceuticals?

出版商 Espicom Business Intelligence
出版日期 2008年09月 商品編碼 74777
內容資訊 英文 Pages: 436
價格
US $ 1215 Hard Copy
US $ 1215 PDF by E-mail (Single user license)
US $ 1215 Web Access (Single user license)


全球主要生物藥品企業介紹 是由出版商Espicom Business Intelligence在2008年09月所出版的。 這份英文市場調查報告書包含Pages: 436 價格從美金1215起跳。

簡介

本報告書內容包括:全球50家主要生物藥品企業的企業概要、R&D動向、產品、合作企業、財務表現等。內容綱要摘記如下:

調查内容

  • 核心人員
  • 企業概要
  • 里程碑
  • R&D產品線
  • 技術
  • 契約
  • 主要財務資料
  • 評價、等

調查目標企業

  • Affymax
  • Ambit Biosciences
  • Ambrx
  • Amylin Pharmaceuticals
  • Arana Therapeutics
  • ARCA biopharma
  • ARIUS Research
  • ARYx Therapeutics
  • Astex Therapeutics
  • BioVex
  • BioXell
  • Bruin Pharmaceuticals
  • Cellectis
  • CombinatoRx
  • Deltanoid Pharmaceuticals
  • Diatos
  • Evotec
  • FivePrime Therapeutics
  • Genmab A/S
  • Idenix Pharmaceuticals
  • Ikaria
  • Infinity Pharmaceuticals
  • Intercytex
  • Ironwood Pharmaceuticals
  • KAI Pharmaceuticals
  • Kalypsys
  • Kereos
  • Micromet
  • Molecular Insight Pharmaceuticals
  • Neuromed Pharmaceuticals
  • Novexel
  • NPS Pharmaceuticals
  • Optimer Pharmaceuticals
  • Palatin Technologies
  • PharmaMar
  • Prana Biotechnology
  • Replidyne
  • S*BIO
  • Sosei
  • Speedel Pharmaceuticals
  • Synta Pharmaceuticals
  • Syntaxin
  • Takara生物
  • Theravance
  • Tranzyme Pharma
  • Trimeris
  • Trubion Pharmaceuticals
  • ViroPharma
  • WILEX
  • Xencor

目錄

Abstract

A critical assessment of leading companies, their research, products, partners and performance

The biopharmaceutical R&D sector is taking an ever more important role in the minds of industry and investors. The potential to fundamentally alter treatment regimes and cure, rather than symptomatically treat, many life-threatening conditions grows greater, but questions remain:

  • Who are the companies that are leading development in this critical area?
  • What is their area of expertise?
  • How substantial is their current product line-up or pipeline projects?
  • With whom are they collaborating?
  • How can you assess their strengths and weaknesses?

Who' s Developing What in Global Biopharmaceuticals? is a new 425 page management guide to 50 significant companies working in the field. From their structure, through collaboration and detailed pipeline evaluation, the report provides an unmatchable window to the future biopharmaceutical corporate environment.

Important areas covered, where available, for each company include:

  • Key Personnel - List of key management
  • Company Overview
  • Milestones - Summary table of key events in the company' s history
  • R&D Pipeline - Products/research by phase and indication
  • Technology - Novel discovery/production technology platforms
  • Agreements - Who' s working with whom? Important alliances identified
  • Key Financial Data - Essential P&L/funding data
  • Appraisal & Evaluation - A critical assessment of the company' s platform, pipeline and corporate environment

Answering key questions such as...

  • With which major pharmaceutical companies is French company Evotec working, and on what?
  • Optimer Pharmaceuticals has eight products in development - what stage are they at and for what are they indicated?
  • What benefit has Astex Therapeutics' Pyramid drug discovery platform brought to the company?

Table of Contents

Affymax

  • Key Personnel
  • Company Overview
  • Milestones
  • R&D Pipeline
  • Technology
  • Agreements
  • Key Financial Data
  • Appraisal & Evaluation

Ambit Bio sciences

Ambrx

Amylin Pharmaceuticals

Arana Therapeutics

ARCA biopharma

ARIUS Research

ARYx Therapeutics

Astex Therapeutics

BioVex

BioXel

Bruin Pharmaceuticals

Celectis

Combinatorx

Deltanoid Pharmaceuticals

Diatos

Evotec

Prime Therapeutics

Genmab A/S

Idenix Pharmaceuticals

Ikaria

Infinity Pharmaceuticals

Intercytex

Ironwod Pharmaceuticals

KAIPharmaceuticals

Kalypsys

Kereos

Micromet

Molecular Insight Pharmaceuticals

Neuromed Pharmaceuticals

Novexel

NPS Pharmaceuticals

Optimer Pharmaceuticals

Palatin Technologies

Pharmamar

Prana Biotechnology

Replidyne

S*BIO

Sosei

Spedel Pharmaceuticals

Synta Pharmaceuticals

Syntaxin

Takara Bio

Theravance

Tranzyme Pharma

Trimeris

Trubion Pharmaceuticals

ViroPharma

WILEX

Xencor

Espicom Analysis

Back to Top